Quantifying changes in local basal ganglia structural connectivity in the 6-hydroxydopamine model of Parkinson's Disease using correlational tractography

被引:0
|
作者
Moshchin, Mikhail [1 ]
Cheng, Kevin P. [1 ]
Osting, Susan [1 ]
Laluzerne, Matthew [1 ]
Hurley, Samuel A. [1 ]
Singh, Ajay Paul [1 ]
Trevathan, James K. [1 ]
Brzeczkowski, Andrea [1 ]
Yu, John-Paul J. [1 ]
Lake, Wendell B. [1 ]
Ludwig, Kip A. [1 ]
Suminski, Aaron J. [1 ]
机构
[1] Univ Wisconsin Madison, Madison, WI 53706 USA
来源
2023 11TH INTERNATIONAL IEEE/EMBS CONFERENCE ON NEURAL ENGINEERING, NER | 2023年
关键词
Parkinson's disease; 6-OHDA; ex-vivo magnetic resonance imaging; diffusion tensor imaging; quantitative anisotropy; deterministic tractography; DEGENERATION; DOPAMINE;
D O I
10.1109/NER52421.2023.10123839
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
In recent years, tractography based on diffusion magnetic resonance imaging (dMRI) has become a popular tool for studying microstructural changes resulting from brain diseases like Parkinson's Disease (PD). Quantitative anisotropy (QA) is a parameter that is used in deterministic fiber tracking as a measure of connection between brain regions. It remains unclear, however, if microstructural changes caused by lesioning the median forebrain bundle (MFB) to create a Parkinsonian rat model can be resolved using tractography based on ex-vivo diffusion MRI. This study aims to fill this gap and enable future mechanistic research on structural changes of the whole brain network rodent models of PD. Specifically, it evaluated the ability of correlational tractography to detect structural changes in the MFB of 6-hydroxydopamine (6-OHDA) lesioned rats. The findings reveal that correlational tractography can detect structural changes in lesioned MFB and differentiate between the 6-OHDA and control groups. Imaging results are supported by behavioral and histological evidence demonstrating that 6-OHDA lesioned rats were indeed Parkinsonian. The results suggest that QA and correlational tractography is appropriate to examine local structural changes in rodent models of neurodegenerative disease. More broadly, we expect that similar techniques may provide insight on how disease alters structure throughout the brain, and as a tool to optimize therapeutic interventions.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Parkinson's Disease and the Heart: Studying Cardiac Metabolism in the 6-Hydroxydopamine Model
    da Fonseca, Victor Silva
    Goncalves, Valeria de Cassia
    Izidoro, Mario Augusto
    de Almeida, Antonio-Carlos Guimaraes
    Fonseca, Fernando Luiz Affonso
    Scorza, Fulvio Alexandre
    Finsterer, Josef
    Scorza, Carla Alessandra
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (15)
  • [32] Afobazole Restores the Dopamine Level in a 6-Hydroxydopamine Model of Parkinson's Disease
    Voronin, M. V.
    Kadnikov, I. A.
    Seredenin, S. B.
    NEUROCHEMICAL JOURNAL, 2019, 13 (01) : 49 - 56
  • [33] The beneficial effect of vanillin on 6-hydroxydopamine rat model of Parkinson's disease
    Abuthawabeh, Rasha
    Abuirmeileh, Amjad N.
    Alzoubi, Karem H.
    RESTORATIVE NEUROLOGY AND NEUROSCIENCE, 2020, 38 (05) : 369 - 373
  • [34] Neuroprotective strategies in Parkinson's disease using the models of 6-hydroxydopamine and MPTP
    Grünblatt, E
    Mandel, S
    Youdim, MBH
    REACTIVE OXYGEN SPECIES: FROM RADIATION TO MOLECULAR BIOLOGY: A FESTSCHRIFT IN HONOR OF DANIEL L GILBERT, 2000, 899 : 262 - 273
  • [35] Dopaminergic Modulation of Basal Ganglia Connectivity in Parkinson's Disease
    Poston, Kathleen L.
    Shire, William
    Joseph, Richard
    Menon, Vinod
    Greicius, Michael
    ANNALS OF NEUROLOGY, 2012, 72 : S138 - S139
  • [36] Dopaminergic Modulation of Basal Ganglia Connectivity in Parkinson's Disease
    Poston, Kathleen L.
    Shire, William
    Joseph, Richard
    Menon, Vinod
    Greicius, Michael
    ANNALS OF NEUROLOGY, 2012, 72 : S109 - S109
  • [37] Characterisation of Behavioural and Neurodegenerative Changes Induced by Intranigral 6-Hydroxydopamine Lesions in a Mouse Model of Parkinson's Disease
    Grealish, S.
    Mattsson, B.
    Draxler, P.
    Bjorklund, A.
    MOVEMENT DISORDERS, 2010, 25 : S634 - S634
  • [38] Characterisation of Behavioural and Neurodegenerative Changes Induced by Intranigral 6-Hydroxydopamine Lesions in a Mouse Model of Parkinson's Disease
    Grealish, S.
    Mattsson, B.
    Draxler, P.
    Bjorklund, A.
    MOVEMENT DISORDERS, 2010, 25 : S633 - S633
  • [39] Motor behavioural changes after intracerebroventricular injection of 6-hydroxydopamine in the rat:: an animal model of Parkinson's disease
    Díaz, MR
    Abdala, P
    Barroso-Chinea, P
    Obeso, J
    González-Hernández, T
    BEHAVIOURAL BRAIN RESEARCH, 2001, 122 (01) : 79 - 92
  • [40] Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson's disease
    Grealish, Shane
    Mattsson, Bengt
    Draxler, Peter
    Bjorklund, Anders
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2010, 31 (12) : 2266 - 2278